Novel anti-melanoma immunotherapies: disarming tumor escape mechanisms.

Clin Dev Immunol · 2012 · PMC3386565 · PMID 22778766

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

CEACAM1 is considered as an independent, highly significant marker for the development of melanoma metastases and poor survival [ 60 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.